Joincare Pharmaceutical Group Industry Co.,Ltd. (SHA: 600380)
China
· Delayed Price · Currency is CNY 9.89
-0.11 (-1.10%)
Sep 6, 2024, 3:00 PM CST
Joincare Pharmaceutical Group Industry Co.,Ltd. Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | 1,404 | 1,443 | 1,503 | 1,328 | 1,120 | 894.35 | Upgrade
|
| Depreciation & Amortization | 849.03 | 1,043 | 837.7 | 620.45 | 546.91 | 522.53 | Upgrade
|
| Other Amortization | 122.3 | 87.55 | 65.57 | 43.99 | 39.28 | 39.3 | Upgrade
|
| Loss (Gain) From Sale of Assets | 2.69 | 2.75 | 17.23 | -17.62 | 1.06 | -1.49 | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.57 | 0.57 | 14.46 | 1.19 | 10.19 | 0.78 | Upgrade
|
| Loss (Gain) From Sale of Investments | -33.05 | -53.39 | 19.68 | -48.52 | -192.52 | -0.45 | Upgrade
|
| Provision & Write-off of Bad Debts | -2.22 | 17.09 | 2.98 | 9.19 | 5.25 | 6.04 | Upgrade
|
| Other Operating Activities | 1,968 | 1,812 | 1,543 | 1,446 | 1,614 | 1,016 | Upgrade
|
| Change in Accounts Receivable | 5,343 | 6,974 | 2,381 | -1,594 | -647.41 | -177.18 | Upgrade
|
| Change in Inventory | -65.34 | -415.39 | -604.73 | -306.33 | -384.21 | -173.94 | Upgrade
|
| Change in Accounts Payable | -5,138 | -7,047 | -1,925 | 1,037 | 963.8 | 196.67 | Upgrade
|
| Change in Other Net Operating Assets | 45.16 | 90.25 | 51.13 | 89.63 | 32.53 | 18.15 | Upgrade
|
| Operating Cash Flow | 4,409 | 3,929 | 3,978 | 2,563 | 3,025 | 2,312 | Upgrade
|
| Operating Cash Flow Growth | 32.32% | -1.23% | 55.19% | -15.27% | 30.81% | 26.67% | Upgrade
|
| Capital Expenditures | -1,123 | -1,130 | -1,148 | -1,521 | -830.41 | -703.2 | Upgrade
|
| Sale of Property, Plant & Equipment | 15.39 | 15.3 | 3.1 | 9.4 | 49.08 | 1.98 | Upgrade
|
| Cash Acquisitions | - | -22.46 | - | - | - | - | Upgrade
|
| Divestitures | - | - | - | 3.31 | 5.34 | - | Upgrade
|
| Investment in Securities | 139.74 | 130.21 | -1,230 | -580.79 | 195.08 | 1,873 | Upgrade
|
| Other Investing Activities | 118.18 | 129.67 | 122.15 | 125.34 | 80.58 | 138.6 | Upgrade
|
| Investing Cash Flow | -849.84 | -877.42 | -2,252 | -1,964 | -500.32 | 1,310 | Upgrade
|
| Long-Term Debt Issued | - | 4,274 | 5,340 | 3,535 | 2,944 | 2,459 | Upgrade
|
| Long-Term Debt Repaid | - | -3,831 | -3,752 | -2,621 | -3,130 | -3,499 | Upgrade
|
| Net Debt Issued (Repaid) | -1,315 | 442.75 | 1,588 | 913.44 | -186.23 | -1,041 | Upgrade
|
| Issuance of Common Stock | 132.26 | 38.12 | 701.08 | 82.58 | 124.68 | - | Upgrade
|
| Repurchase of Common Stock | -444.42 | -821.54 | -780.55 | -938.08 | -503.7 | -0.03 | Upgrade
|
| Common Dividends Paid | -478.84 | -480.86 | -389.04 | -382.47 | -360.94 | -375.37 | Upgrade
|
| Other Financing Activities | -292.95 | -1,106 | -553.15 | -650.36 | -312.03 | -643.94 | Upgrade
|
| Financing Cash Flow | -2,399 | -1,927 | 566.12 | -974.9 | -1,238 | -2,060 | Upgrade
|
| Foreign Exchange Rate Adjustments | -24.93 | 38.41 | 189.29 | -49.29 | -103.99 | 17.22 | Upgrade
|
| Net Cash Flow | 1,135 | 1,162 | 2,481 | -425.26 | 1,182 | 1,580 | Upgrade
|
| Free Cash Flow | 3,286 | 2,799 | 2,830 | 1,042 | 2,195 | 1,609 | Upgrade
|
| Free Cash Flow Growth | 37.91% | -1.10% | 171.67% | -52.53% | 36.37% | 37.48% | Upgrade
|
| Free Cash Flow Margin | 20.33% | 16.81% | 16.51% | 6.55% | 16.23% | 13.43% | Upgrade
|
| Free Cash Flow Per Share | 1.75 | 1.47 | 1.49 | 0.54 | 1.12 | 0.83 | Upgrade
|
| Cash Income Tax Paid | 215.97 | 140.04 | 103.82 | -0.08 | 1,286 | 1,282 | Upgrade
|
| Levered Free Cash Flow | 2,617 | 1,771 | 1,593 | 424.23 | 1,576 | 923.78 | Upgrade
|
| Unlevered Free Cash Flow | 2,710 | 1,863 | 1,680 | 480.65 | 1,599 | 963.21 | Upgrade
|
| Change in Net Working Capital | -1,024 | -12.58 | -69.08 | 304.67 | -280.43 | 33.81 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.